Depuy Synthes ATTUNE Revision Hinge Knee Inserts Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
DePuy (Ireland) is recalling 160 units of ATTUNE Revision Hinge Knee Hinge Insert Components due to potential sterility compromise from adhered packaging.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 7, 2026 and geographically references Minnesota, North Carolina, Texas. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
DePuy (Ireland) initiated a voluntary recall of certain ATTUNE Revision Hinge Knee Hinge Insert Components after the external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility.
Which Products Are Affected
The recall covers 40 specific Depuy Synthes ATTUNE KNEE SYSTEM REVISION HINGE INSERT models with part numbers including 151730410, 151730412, 151730414, 151730416, 151730418, 151730420, 151730422, 151730424, 151730426, 151730408, 151730510, 151730512, 151730514, 151730516, 151730518, 151730520, 151730522, 151730524, 151730526, 151730508, 151730710, 151730712, 151730714, 151730716, 151730718, 151730720, 151730722, 151730724, 151730726, 151730708, 151730810, 151730812, 151730814, 151730816, 151730818, 151730820, 151730822, 151730808, 151730824, and 151730826. A total of 160 units distributed to Minnesota, North Carolina, and Texas are affected. Associated GTINs and lot numbers are detailed in FDA recall Z-2617-2026.
What You Should Do
No specific consumer instructions are provided in the recall notice. The action is classified as Class II and was initiated voluntarily by the firm.
Why This Matters
The recall involves medical devices distributed in three U.S. states where compromised sterility could affect product safety.
Source
FDA recall number Z-2617-2026, report date 20260708.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,388 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.